HEFEI, June 7 (Xinhua) -- Chinese scientists have demonstrated the effectiveness of early insulin therapy for newly diagnosed patients with type 2 diabetes (T2D), which can reduce the risks of stroke and hospitalization due to heart failure compared to those who have not received the treatment. ...
diabetes.Methods:We conducted a 26-week,randomized,double-blind,double-dummy,phase 2 trial to investigate the efficacy and safety of once-weekly insulin icodec as compared with once-daily insulin glargine U100 in patients who had not previously received long-term insulin treatment and whose type 2...
Afrezza, a rapid-acting inhaled insulin, is FDA-approved for use before meals for both type 1 and type 2 diabetes. The drug peaks in your blood in about 15-20 minutes and it clears your body in 2-3 hours. It must be used along with long-acting insulin in people with type 1 diabete...
At the time of diagnosis, your health care provider might recommend certain pharmacological and non-pharmacological treatments for your type 2 diabetes. The main goal of treatment is toprevent or delay diabetes complications. Type 2 diabetes is a progressive condition, meaning that it can get worse...
Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Insulin pump therapy (continuous subcutaneous insulin infusion [CSII]) is now an established form of intensive insulin treatment. It is pertinent to ask, h... JC Pickup,E Renard - 《Di...
The progressive nature of type 2 diabetes necessitates that treatment is intensified as the disease advances. Several studies have shown that basal insulin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) can be used in combination to successfully improve glycemic control and this combination...
youtube.com瑞典卡罗林斯卡学院(Karolinska Institutet)的研究人员发现了一种名为CID 661578的分子,它有助于刺激新的胰岛素生成细胞的生长,并揭示了它的工作原理,开辟了新的潜在糖尿病治疗方法。这种分子与一种叫做MNK2的蛋白质结合,导致更大的β细胞再生,更高的胰岛素
对死于1型糖尿病患者的早期尸检研究帮助我们认识到了胰腺中发生的病理性改变。在 1型糖尿病中,胰岛内会发生免疫反应介导的进行性β细胞退化,最终导致胰岛素的分泌近乎完全停止。在2型糖尿病中,由于β细胞凋亡增加,β细胞数量会发生锐减。 [7]Islet pathology in diabetes ...
Objective To evaluate the cost-effectiveness of insulin aspart 30 and premixed protamine biosynthetic human insulin 30R for the treatment of type 2 diabetes. Methods A total of 40 patients with type 2 diabetes were randomly diveded into group A and group B,in which they were respectively treated...
youtube.com 瑞典卡罗林斯卡学院(Karolinska Institutet)的研究人员发现了一种名为CID 661578的分子,它有助于刺激新的胰岛素生成细胞的生长,并揭示了它的工作原理,开辟了新的潜在糖尿病治疗方法。这种分子与一种叫做MNK2的蛋白质结合,导致更大的β细胞再生,更高的胰岛素产生和更低的血糖水平。 生物 健康 科普 知识 ...